News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
51 Results
Type
Article (3)
Company Profile (1)
Press Release (47)
Section
Business (12)
Career Advice (1)
Drug Development (3)
Job Trends (3)
News (14)
Tag
Academia (1)
Alliances (1)
Autoimmune disease (1)
Biotechnology (1)
Cancer (1)
Clinical research (7)
Collaboration (1)
C-suite (1)
Data (1)
Diabetes (1)
Earnings (18)
Events (10)
Immunology and inflammation (3)
Labor market (1)
Layoffs (2)
Mergers & acquisitions (1)
Metabolic disorders (1)
People (3)
Phase 1 (4)
Phase 2 (5)
Pipeline (4)
Prostate cancer (1)
Real estate (1)
Regulatory (1)
Reports (1)
Special edition (1)
Date
Last 365 days (14)
2026 (1)
2025 (14)
2024 (25)
2023 (7)
2022 (1)
2021 (1)
2017 (1)
Location
California (2)
Europe (25)
Maryland (9)
New York (1)
Pennsylvania (7)
Southern California (1)
United States (19)
51 Results for "barinthus biotherapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
December 10, 2025
·
6 min read
Press Releases
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
November 10, 2025
·
17 min read
Press Releases
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
October 1, 2025
·
19 min read
Press Releases
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics
October 27, 2025
·
2 min read
Press Releases
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
August 8, 2025
·
12 min read
Press Releases
Barinthus Biotherapeutics’ CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025
June 9, 2025
·
2 min read
Press Releases
Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
May 7, 2025
·
14 min read
Press Releases
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
March 6, 2025
·
1 min read
Press Releases
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
March 20, 2025
·
16 min read
Business
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, announced its financial results for the year ended December 31, 2023, and an overview of the Company’s progress.
March 20, 2024
·
14 min read
1 of 6
Next
